A detailed history of Manufacturers Life Insurance Company, The transactions in Glaukos Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 28,343 shares of GKOS stock, worth $4.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,343
Previous 27,711 2.28%
Holding current value
$4.44 Million
Previous $3.28 Million 12.6%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$113.62 - $135.39 $71,807 - $85,566
632 Added 2.28%
28,343 $3.69 Million
Q2 2024

Aug 14, 2024

BUY
$89.48 - $118.35 $172,338 - $227,942
1,926 Added 7.47%
27,711 $3.28 Million
Q1 2024

May 14, 2024

SELL
$76.4 - $96.33 $1.22 Million - $1.53 Million
-15,927 Reduced 38.18%
25,785 $2.43 Million
Q4 2023

Feb 13, 2024

BUY
$59.53 - $85.11 $1 Million - $1.44 Million
16,875 Added 67.94%
41,712 $3.32 Million
Q3 2023

Nov 15, 2023

BUY
$69.23 - $79.09 $415,795 - $475,014
6,006 Added 31.89%
24,837 $1.87 Million
Q2 2023

Aug 11, 2023

BUY
$45.44 - $71.21 $27,400 - $42,939
603 Added 3.31%
18,831 $1.34 Million
Q1 2023

May 15, 2023

BUY
$43.88 - $52.48 $3,247 - $3,883
74 Added 0.41%
18,302 $916,000
Q4 2022

Aug 11, 2023

BUY
$40.82 - $57.75 $3,102 - $4,389
76 Added 0.42%
18,228 $796,000
Q4 2022

Feb 13, 2023

BUY
$40.82 - $57.75 $3,102 - $4,389
76 Added 0.42%
18,228 $796,000
Q3 2022

Aug 11, 2023

SELL
$46.84 - $58.49 $16,815 - $20,997
-359 Reduced 1.94%
18,152 $966,000
Q3 2022

Nov 03, 2022

SELL
$46.84 - $58.49 $16,815 - $20,997
-359 Reduced 1.94%
18,152 $966,000
Q2 2022

Aug 11, 2023

SELL
$34.86 - $63.77 $6,727 - $12,307
-193 Reduced 1.03%
18,511 $840,000
Q2 2022

Aug 15, 2022

SELL
$34.86 - $63.77 $6,727 - $12,307
-193 Reduced 1.03%
18,511 $841,000
Q1 2022

Aug 11, 2023

BUY
$44.33 - $57.82 $17,820 - $23,243
402 Added 2.2%
18,704 $1.08 Million
Q1 2022

May 20, 2022

SELL
$44.33 - $57.82 $189,067 - $246,602
-4,265 Reduced 18.57%
18,704 $1.08 Million
Q4 2021

Feb 16, 2022

SELL
$40.27 - $56.99 $4,711 - $6,667
-117 Reduced 0.51%
22,969 $1.02 Million
Q3 2021

Nov 12, 2021

SELL
$47.43 - $84.23 $100,361 - $178,230
-2,116 Reduced 8.4%
23,086 $1.11 Million
Q2 2021

Aug 12, 2021

BUY
$73.06 - $97.7 $88,037 - $117,728
1,205 Added 5.02%
25,202 $2.14 Million
Q1 2021

May 03, 2021

SELL
$70.43 - $97.42 $109,448 - $151,390
-1,554 Reduced 6.08%
23,997 $2.01 Million
Q4 2020

Feb 12, 2021

BUY
$48.9 - $75.26 $42,738 - $65,777
874 Added 3.54%
25,551 $1.92 Million
Q3 2020

Nov 09, 2020

SELL
$37.23 - $50.97 $18,615 - $25,485
-500 Reduced 1.99%
24,677 $1.22 Million
Q2 2020

Aug 10, 2020

BUY
$28.78 - $46.83 $10,591 - $17,233
368 Added 1.48%
25,177 $961,000
Q1 2020

May 15, 2020

BUY
$25.53 - $70.14 $37,733 - $103,666
1,478 Added 6.33%
24,809 $766,000
Q4 2019

Feb 14, 2020

BUY
$54.18 - $65.64 $73,847 - $89,467
1,363 Added 6.2%
23,331 $1.27 Million
Q3 2019

Nov 12, 2019

SELL
$58.58 - $83.91 $5,799 - $8,307
-99 Reduced 0.45%
21,968 $1.34 Million
Q2 2019

Aug 14, 2019

SELL
$63.59 - $78.71 $8,457 - $10,468
-133 Reduced 0.6%
22,067 $1.66 Million
Q1 2019

May 13, 2019

BUY
$50.75 - $80.54 $89,218 - $141,589
1,758 Added 8.6%
22,200 $1.74 Million
Q4 2018

Feb 14, 2019

SELL
$52.18 - $67.93 $57,398 - $74,723
-1,100 Reduced 5.11%
20,442 $1.15 Million
Q3 2018

Nov 14, 2018

SELL
$38.13 - $68.37 $185,197 - $332,073
-4,857 Reduced 18.4%
21,542 $1.4 Million
Q2 2018

Aug 14, 2018

BUY
$27.62 - $44.51 $88,825 - $143,144
3,216 Added 13.87%
26,399 $1.07 Million
Q1 2018

May 15, 2018

BUY
$26.05 - $34.5 $16,698 - $22,114
641 Added 2.84%
23,183 $715,000
Q4 2017

Feb 08, 2018

BUY
$24.5 - $36.01 $9,212 - $13,539
376 Added 1.7%
22,542 $578,000
Q3 2017

Nov 14, 2017

BUY
$31.26 - $42.03 $692,909 - $931,636
22,166
22,166 $731,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.